Cargando…

The impact of obesity and overweight on medical expenditures and disease incidence in Korea from 2002 to 2013

OBJECTIVES: Few studies have assessed the long-term medical costs and incidence of obesity and overweight in Asia. We evaluated the impact of body mass index (BMI) on medical expenditures and disease incidence and prevalence over more than 10 years in South Korea. METHODS: Using 2002–2013 data from...

Descripción completa

Detalles Bibliográficos
Autores principales: Song, Hyun Jin, Hwang, Jinseub, Pi, Seonmi, Ahn, Sena, Heo, Yoonseok, Park, Susan, Kwon, Jin-Won
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5944944/
https://www.ncbi.nlm.nih.gov/pubmed/29746509
http://dx.doi.org/10.1371/journal.pone.0197057
_version_ 1783321910071787520
author Song, Hyun Jin
Hwang, Jinseub
Pi, Seonmi
Ahn, Sena
Heo, Yoonseok
Park, Susan
Kwon, Jin-Won
author_facet Song, Hyun Jin
Hwang, Jinseub
Pi, Seonmi
Ahn, Sena
Heo, Yoonseok
Park, Susan
Kwon, Jin-Won
author_sort Song, Hyun Jin
collection PubMed
description OBJECTIVES: Few studies have assessed the long-term medical costs and incidence of obesity and overweight in Asia. We evaluated the impact of body mass index (BMI) on medical expenditures and disease incidence and prevalence over more than 10 years in South Korea. METHODS: Using 2002–2013 data from the Korean National Claims Database, we analysed two population sets (initial BMI in 2002–2003; consistent BMI in 2002–2003 and 2012–2013). Obesity was defined by Asian BMI criteria. Incremental medical expenditures or Charlson Comorbidity Index (CCI) ratios for obese compared to normal weight individuals were calculated. Medical expenditure over 11 years was estimated by BMI using a generalised linear model. Individual obesity-related disease incidence was determined and adjusted hazard ratios were calculated. RESULTS: Data for 496,469 and 214,477 individuals were included in the entire and consistent BMI level populations, respectively. Average CCI score change in normal weight and the obesity III (BMI 35–59.99 kg/m(2)) group over 11 years were 0.94 and 1.56, respectively in the entire population, and incremental ratio in the obesity III group was 66.0% compared to the normal weight group. In consistent BMI level population, incremental ratio (92.1%) for obesity III was higher than entire population. Medical costs in the obesity III groups versus the normal weight group in the entire and consistent BMI level populations increased by 38.4% and 77.1%, respectively. Over 11 years, individuals with BMI ≥30 kg/m(2) in the entire and consistent BMI level populations had post-adjustment medical expenditures of 1.13–1.20 and 1.21–1.40 times the normal weight group, respectively. Incidence rate and adjusted hazard ratio of obesity-related disease increased in the obesity groups compared to the normal weight group. CONCLUSIONS: Our findings emphasize the importance of the effective and sustainable obesity management strategies, considering the dramatic increase in obesity (BMI ≥30 kg/m(2)) in South Korea.
format Online
Article
Text
id pubmed-5944944
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-59449442018-05-25 The impact of obesity and overweight on medical expenditures and disease incidence in Korea from 2002 to 2013 Song, Hyun Jin Hwang, Jinseub Pi, Seonmi Ahn, Sena Heo, Yoonseok Park, Susan Kwon, Jin-Won PLoS One Research Article OBJECTIVES: Few studies have assessed the long-term medical costs and incidence of obesity and overweight in Asia. We evaluated the impact of body mass index (BMI) on medical expenditures and disease incidence and prevalence over more than 10 years in South Korea. METHODS: Using 2002–2013 data from the Korean National Claims Database, we analysed two population sets (initial BMI in 2002–2003; consistent BMI in 2002–2003 and 2012–2013). Obesity was defined by Asian BMI criteria. Incremental medical expenditures or Charlson Comorbidity Index (CCI) ratios for obese compared to normal weight individuals were calculated. Medical expenditure over 11 years was estimated by BMI using a generalised linear model. Individual obesity-related disease incidence was determined and adjusted hazard ratios were calculated. RESULTS: Data for 496,469 and 214,477 individuals were included in the entire and consistent BMI level populations, respectively. Average CCI score change in normal weight and the obesity III (BMI 35–59.99 kg/m(2)) group over 11 years were 0.94 and 1.56, respectively in the entire population, and incremental ratio in the obesity III group was 66.0% compared to the normal weight group. In consistent BMI level population, incremental ratio (92.1%) for obesity III was higher than entire population. Medical costs in the obesity III groups versus the normal weight group in the entire and consistent BMI level populations increased by 38.4% and 77.1%, respectively. Over 11 years, individuals with BMI ≥30 kg/m(2) in the entire and consistent BMI level populations had post-adjustment medical expenditures of 1.13–1.20 and 1.21–1.40 times the normal weight group, respectively. Incidence rate and adjusted hazard ratio of obesity-related disease increased in the obesity groups compared to the normal weight group. CONCLUSIONS: Our findings emphasize the importance of the effective and sustainable obesity management strategies, considering the dramatic increase in obesity (BMI ≥30 kg/m(2)) in South Korea. Public Library of Science 2018-05-10 /pmc/articles/PMC5944944/ /pubmed/29746509 http://dx.doi.org/10.1371/journal.pone.0197057 Text en © 2018 Song et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Song, Hyun Jin
Hwang, Jinseub
Pi, Seonmi
Ahn, Sena
Heo, Yoonseok
Park, Susan
Kwon, Jin-Won
The impact of obesity and overweight on medical expenditures and disease incidence in Korea from 2002 to 2013
title The impact of obesity and overweight on medical expenditures and disease incidence in Korea from 2002 to 2013
title_full The impact of obesity and overweight on medical expenditures and disease incidence in Korea from 2002 to 2013
title_fullStr The impact of obesity and overweight on medical expenditures and disease incidence in Korea from 2002 to 2013
title_full_unstemmed The impact of obesity and overweight on medical expenditures and disease incidence in Korea from 2002 to 2013
title_short The impact of obesity and overweight on medical expenditures and disease incidence in Korea from 2002 to 2013
title_sort impact of obesity and overweight on medical expenditures and disease incidence in korea from 2002 to 2013
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5944944/
https://www.ncbi.nlm.nih.gov/pubmed/29746509
http://dx.doi.org/10.1371/journal.pone.0197057
work_keys_str_mv AT songhyunjin theimpactofobesityandoverweightonmedicalexpendituresanddiseaseincidenceinkoreafrom2002to2013
AT hwangjinseub theimpactofobesityandoverweightonmedicalexpendituresanddiseaseincidenceinkoreafrom2002to2013
AT piseonmi theimpactofobesityandoverweightonmedicalexpendituresanddiseaseincidenceinkoreafrom2002to2013
AT ahnsena theimpactofobesityandoverweightonmedicalexpendituresanddiseaseincidenceinkoreafrom2002to2013
AT heoyoonseok theimpactofobesityandoverweightonmedicalexpendituresanddiseaseincidenceinkoreafrom2002to2013
AT parksusan theimpactofobesityandoverweightonmedicalexpendituresanddiseaseincidenceinkoreafrom2002to2013
AT kwonjinwon theimpactofobesityandoverweightonmedicalexpendituresanddiseaseincidenceinkoreafrom2002to2013
AT songhyunjin impactofobesityandoverweightonmedicalexpendituresanddiseaseincidenceinkoreafrom2002to2013
AT hwangjinseub impactofobesityandoverweightonmedicalexpendituresanddiseaseincidenceinkoreafrom2002to2013
AT piseonmi impactofobesityandoverweightonmedicalexpendituresanddiseaseincidenceinkoreafrom2002to2013
AT ahnsena impactofobesityandoverweightonmedicalexpendituresanddiseaseincidenceinkoreafrom2002to2013
AT heoyoonseok impactofobesityandoverweightonmedicalexpendituresanddiseaseincidenceinkoreafrom2002to2013
AT parksusan impactofobesityandoverweightonmedicalexpendituresanddiseaseincidenceinkoreafrom2002to2013
AT kwonjinwon impactofobesityandoverweightonmedicalexpendituresanddiseaseincidenceinkoreafrom2002to2013